Intensity of Humoral Immune Responses, Adverse Reactions, and Post-Vaccination Morbidity after Adenovirus Vector-Based and mRNA Anti-COVID-19 Vaccines.
Voulgaridi I, Sarrou S, Dadouli A, Peristeri AM, Nasika A, Onoufriadis I, Kyritsi MA, Anagnostopoulos L, Theodoridou A, Avakian I, Pappa D, Konstantinou AK, Papadamou G, Mouchtouri VA, Petinaki E, Speletas M, Hadjichristodoulou C.
Voulgaridi I, et al. Among authors: pappa d.
Vaccines (Basel). 2022 Aug 6;10(8):1268. doi: 10.3390/vaccines10081268.
Vaccines (Basel). 2022.
PMID: 36016156
Free PMC article.